Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPTBN1 antisense RNA 1 (SPTBN1-AS1) is an annotated long non-coding RNA gene with limited functional characterization to date. It is transcribed in the antisense orientation relative to the SPTBN1 coding gene, which encodes the spectrin beta chain, brain 1 protein. Unlike SPTBN1, which is a well-studied cytoskeletal protein with established roles in cell structure, signaling, and disease, the functions, biological impact, and potential disease associations of SPTBN1-AS1 are currently not well defined in the literature. There are no established roles for SPTBN1-AS1 as a biomarker, drug target, or mechanism of action for therapeutics at this time[3][6]. Most published data and disease associations refer to SPTBN1 (protein-coding) and not to SPTBN1-AS1 (non-coding RNA). If you are specifically interested in the protein-coding SPTBN1 (Spectrin beta chain, brain 1), its molecular and disease relevance is entirely distinct[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SPTBN1 antisense RNA 1 (SPTBN1-AS1).